Xcerra Announces Microchip Technology as the Recipient of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
18
Xcerra Announces Microchip Technology as the Recipient of the 500th Diamondx Test System

NORWOOD, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Xcerra (Nasdaq: XCRA ), today announced that it has shipped the 500 th Diamondx test system, reaching a critical milestone for Xcerra’s flagship system-on-a-chip (SOC) test system. The 500 th test system was delivered to Microchip Technology (Nasdaq: MCHP ), the number three supplier of microcontrollers in the world. Microchip will add to their installed base of Diamondx testers in support of high volume production test of devices supplied into the automotive, consumer and industrial markets.

The capabilities of the Diamondx provide customers with the ability to use a test system that incorporates the latest technology for delivering the lowest cost of test while offering instrumentation that can support a wide range of performance requirements, including precision analog, high speed SERDES digital and mmWave RF. The architecture of the Diamondx incorporates unique capabilities such as an Integrated Multi-System Architecture, or IMA, that allows customers to better match the test requirements of a device with the cost profile of the test system, thereby achieving the lowest cost of test.

Ganesh Moorthy, president and chief operating officer at Microchip Technology, commented, “Diamondx is not only used for testing microcontrollers, we also rely on the system for high volume manufacturing test of our wireless, networking (USB, Ethernet, MOST, etc.), touch controller and other mixed-signal products. Xcerra provides outstanding technical support in all phases of test development and high volume production test, and when combined with the economics delivered by the Diamondx, this creates a powerful combination. All in all, Xcerra is a high class organization that develops solutions that address our current and future business needs.”

David Tacelli, president and chief executive officer for Xcerra, commented, “Our goal is to develop the semiconductor test solutions that deliver a powerful combination of performance and economic value complemented by world-class customer support. The growing adoption of the Diamondx by top tier semiconductor suppliers such as Microchip is validation that our strategy is succeeding.”

About Microchip Technology Microchip Technology Inc. (NASDAQ: MCHP ) is a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, providing low-risk product development, lower total system cost and faster time to market for thousands of diverse customer applications worldwide.  Headquartered in Chandler, Arizona, Microchip offers outstanding technical support along with dependable delivery and quality.  For more information, visit the Microchip website at www.microchip.com.

About Xcerra Xcerra is comprised of two reporting segments; Semiconductor Test Solutions (STS) and Electronics Manufacturing Solutions (EMS). The STS segment supplies semiconductor testers, test handlers, device contactors and associated services. The EMS segment offers products and services for PCB and PCBA test as well as innovative and highly reliable interconnect components for electronic manufacturing.  The combination of these businesses creates a Company with a broad spectrum of semiconductor and PCB test expertise that drive innovative new products and services, and the ability to deliver to customers fully integrated semiconductor test cell solutions.  The Company’s products and services address the broad and divergent requirements of the mobility, automotive, industrial and consumer end markets, offering a comprehensive portfolio of solutions and technologies, and a global network of strategically deployed applications and support resources. Additional information can be found at www.xcerra.com .

trade press interested in technology, products   please contact Barbara Loferer Xcerra Corporation 825 University Avenue  Norwood, MA 02062-2643  Phone : +49 8031 406 216 E-mail: barbara.loferer@Xcerra.com   financial media interested in corporate news please contact  Rich Yerganian Xcerra Corporation 825 University Avenue  Norwood, MA 02062-2643  Phone : +1.781-467.5063 E-mail: rich.yerganian@Xcerra.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Dynamics of Texas Instruments' Short Interest

Updated Category News Views 124

Delving into the Short Interest of Texas Instruments Texas Instruments TXN has recently seen a notable decrease in its short interest, which has fallen by 12.71% since the last report. As of the latest figures, the company reported that approximately 16.83 million shares have been sold short, representing around 2.06% of all shares available for trading. With these...

Continue Reading
Nuvoton Launches Revolutionary 1.7W Indigo Laser Diode

Updated Category News Views 343

Nuvoton Introduces an Innovative Indigo Laser Diode Nuvoton Technology Corporation Japan, widely known as NTCJ, has celebrated another milestone in laser technology with the introduction of their groundbreaking indigo semiconductor laser. This innovative product boasts an impressive optical output power of 1.7 W and operates at a wavelength of 420 nm, making it a...

Continue Reading
Exploring the Surge in Japanese Stocks Amid Political Changes

Updated Category News Views 121

Japanese Stocks Reach New Heights In recent times, Japanese stocks have soared to impressive new highs, buoyed by a combination of economic factors and political dynamics. A notable factor in this surge has been a weakening yen, coupled with increasing bond yields, coinciding with discussions around potential snap elections initiated by Prime Minister Sanae Takaichi....

Continue Reading
TGS Enhances Summer Operations in Northern Europe with Vessels

Updated Category News Views 183

TGS Expands Summer Operations in Northern Europe TGS, a renowned provider of energy data and intelligence, has reported an exciting summer season ahead in Northern Europe. This year, the company has not only increased its acquisition capacity but has also enhanced its operational efficiency with the deployment of four acquisition vessels in the region: three seismic...

Continue Reading
Zentalis Pharmaceuticals Welcomes James B. Bucher as CLO

Updated Category News Views 152

Zentalis Pharmaceuticals Strengthens Leadership with New Appointment In a significant move, Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL), a clinical-stage biopharmaceutical company focused on innovative therapies for cancer treatment, is thrilled to announce the appointment of James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary. This strategic step comes...

Continue Reading